This is an old revision of this page, as edited by Monkbot(talk | contribs) at 01:13, 20 October 2020(→top: Task 17: replace to-be-deprecated: |name-list-format= (2× replaced; usage: 2 of 2);). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 01:13, 20 October 2020 by Monkbot(talk | contribs)(→top: Task 17: replace to-be-deprecated: |name-list-format= (2× replaced; usage: 2 of 2);)
^Shapiro S, Weinburg K, Freedman L (1956). "Notes - Long-Acting Androgens". The Journal of Organic Chemistry. 21 (11): 1300–1302. doi:10.1021/jo01117a602. ISSN0022-3263.
^Gould D, Finckenor L, Hershberg EB, Cassidy J, Perlman PL (1957). "Long-acting Testosterone Esters. Some Considerations on their Biological Utilization1". Journal of the American Chemical Society. 79 (16): 4472–4475. doi:10.1021/ja01573a061. ISSN0002-7863.
^Aakvaag A, Vogt JH (March 1969). "Plasma testosterone values in different forms of testosterone treatment". Acta Endocrinologica. 60 (3): 537–42. doi:10.1530/acta.0.0600537. PMID5395873. Triolandren®, for intramuscular use, kindly supplied by Ciba, Basel, through Kobro 8c Co., Oslo, containing three different testosterone esters, in the following amounts of testosterone equivalents per ml oil: propionate 20 mg; valerate 80 mg; undecylenate 150 mg.
^Zachmann M, Prader A (January 1970). "Anabolic and androgenic affect of testosterone in sexually immature boys and its dependency on growth hormone". The Journal of Clinical Endocrinology and Metabolism. 30 (1): 85–95. doi:10.1210/jcem-30-1-85. PMID4311616. Triolandren, CIBA; 250 mg of this preparation contains 20 mg of testosterone propionate, 80 mg of testosterone-n-valerianate, and 150 mg of testosterone undecylenate—250 mg thus contains 173.8 mg of testosterone; the remaining 76.2 mg consists of the ester components [...]